Prognostic value of stress 99mTc-tetrofosmin myocardial perfusion imaging in predicting all-cause mortality: A 6-year follow-up study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 10, 2006, Pages 1157-1161

  Elhendy, Abdou ^a,b   Schinkel, Arend F L ^a   Van Domburg, Ron T ^a   Bax, Jeroen J ^c   Valkema, Roelf ^a   Biagini, Elena ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Prognosis; Radionuclide imaging; Stress test

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; GROUPS BY AGE; HEART FAILURE; HEART MUSCLE PERFUSION; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREDICTION; PREDICTOR VARIABLE; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; STATISTICAL ANALYSIS; STRESS; TOMOGRAPHY;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; VASODILATOR AGENTS;

EID: 33749255006     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0140-4     Document Type: Article

References (26)

1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-1333
2. 99mTc sestamibi. Radiology 2004;232:58-65
3. Calnon DA, McGrath PD, Doss AL, Harrell FE Jr, Watson DD, Beller GA. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol 2001;38:1511-1517
4. Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, et al. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 2003;91:408-411
5. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62
6. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005;45:722-729
7. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-647
8. Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med 2002;43:1634-1646
9. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-914
10. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-1478
11. Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Valkema R, Poldermans D. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: Impact of scintigraphic extent of coronary artery disease. J Nucl Cardiol 2004;11:704-709
12. Jain D. Technetium-99m labeled myocardial perfusion imaging agents. Semin Nucl Med 1999;29:221-236.
13. Gottlieb SS. Dead is dead-artificial definitions are no substitute. Lancet 1997;349:662-663
14. Sorlie PD, Gold EB. The effect of physician terminology preference on coronary heart disease mortality: an artifact uncovered by the 9th revision ICD. Am J Public Health 1987;77:148-152
15. Kircher T, Anderson RE. Cause of death: proper completion of the death certificate. JAMA 1987;258:349-352
16. Zumwalt RE, Ritter MR. Incorrect death certification: an invitation to obfuscation. Postgrad Med 1987;81:245-254
17. 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2005;46:2003-2008
18. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med 1998;158:2007-2014
19. Prescott E, Osler M, Andersen PK, Hein HO, Borch-Johnsen K, Lange P, et al. Mortality in women and men in relation to smoking. Int J Epidemiol 1998;27:27-32
20. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J, et al. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 2003;164:1438-1443
21. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-2113
22. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62
23. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Poldermans D. Prediction of all-cause mortality in women with known or suspected coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol 2004;93:450-452
24. Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001;37:754-760
25. Elhendy A, Mahoney DW, McCully RB, Seward JB, Burger KN, Pellikka PA. Use of a scoring model combining clinical, exercise test, and echocardiographic data to predict mortality in patients with known or suspected coronary artery disease. Am J Cardiol 2004;93:1223-1228
26. Biagini E, Elhendy A, Schinkel AF, Rizzello V, van Domburg RT, Krenning BJ, et al. Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test results. Am J Cardiol 2005;95:1072-1075